Skip to main content
. 2015 Feb 19;(2):1–115. doi: 10.1002/14651858.CD008152.pub4

Kolaczinski 2012

Methods Individually RCT Dates of trial: between July and January, from 2000 to 2003.

Participants 237 individuals aged from 3 to 70 years, in 5 villages for Afghan refugees in Pakistan. Inclusion: = 2 years of age, P. falciparum mono-infection, confirmed by slide, will be resident during entire follow-up period. Exclusions: Pregnancy, signs of severe malaria, report of antimalarial drug in past 21 days, other serious disease

Interventions 1. CQ: 3 days 25 mg/kg. 2. CQ+PQ: CQ as in 1; PQ on day 3 (0.5 mg/kg). 3. SP: 25(S)/1.25(P) mg/kg in single dose. 4. SP+PQ: SP as in 3; PQ on same day (0.5 mg/kg).

Outcomes 1. Clinical treatment failure (PCR non-adjusted and adjusted). 2. Gametocytes on day 8. 3. Gametocyte density on days 1 to 8 of follow-up. 4. Genotyping of resistant strains for CQ and SP-specific mutations.

Notes Also included CQ + AS and SP + AS arms, compared with CQ +/- PQ and SP +/- PQ arms, respectively.

Risk of bias

Bias Authors' judgement Support for judgement

Random sequence generation (selection bias) Low risk Patients numbered sequentially at enrolment. Random numbers with treatment assignment from Excel-generated lists, then paired with patient numbers.

Allocation concealment (selection bias) Low risk Patient number concealed until after enrolment.

Incomplete outcome data (attrition bias) All outcomes Low risk 209 of 237 randomized completed treatment and at least one follow-up test. 47 (13%) of those randomized did not contribute data. Variable numbers tested during follow-up (see analyses).

Selective reporting (reporting bias) Low risk None detected.

Other bias Low risk None noted.

Blinding of participants and personnel (performance bias) All outcomes High risk Identified in report as 'single-blind'. Manager (gave Rx) not blinded; patients, microscopists and health workers 'partially blinded' due to different drug appearance and times of follow-up. No placebos used, but vitamin given to those in non-PQ arms.

Blinding of outcome assessment (detection bias) All outcomes Low risk Implied only.